FTC settles with four over alleged EU-U.S. Privacy Shield deception
By 
Jaclyn Jaeger2019-12-05T19:48:00
Four companies have reached settlements with the Federal Trade Commission for allegedly misrepresenting their participation in the EU-U.S. Privacy Shield framework.
THIS IS MEMBERS-ONLY CONTENT
You are not logged in and do not have access to members-only content.
If you are already a registered user or a member, SIGN IN now.
Related articles
-
ArticleTop EU advisor: Clauses used for EU-U.S. data transfers ‘valid’
Big Tech can breathe a sigh of a relief that the mechanisms it uses to transfer data outside of the European Union to “third countries” provide sufficient privacy protection, according to a key advisor to the EU’s top court.
-
ArticleFTC warns of false compliance with EU-U.S. Privacy Shield
The Federal Trade Commission is warning over a dozen companies in the form of letters not to falsely claim participation in the EU-U.S. Privacy Shield program.
-
Blog
FTC: Four companies falsely claimed certification under EU-U.S. Privacy Shield
Four companies have agreed to settle allegations by the Federal Trade Commission that they falsely claimed certification under the EU-U.S. Privacy Shield framework and that two of these companies failed to abide by a key provision of the framework.
More from Regulatory Enforcement
-
ArticleFrench investigators target anticompetitive practices in largest accounting firms
Major accountancy firms in France are under investigation for anti-competitive practices. The French competition watchdog embarked on a series of “unannounced inspections” and removed documents relating to audit and reporting on Jan. 13.
-
ArticleEU investigation into Grok may expose problems with DSA rather than compliance failings
The European Commission has launched a formal investigation against Elon Musk’s X under the Digital Services Act over fears that its AI tool Grok may be producing and disseminating illegal material.
-
ArticleFormer ADM execs inflated operating profits, SEC alleges
Three former executives at Archer-Daniels-Midland intentionally misled investors by inflating the performance of the company’s Nutrition unit, the U.S. Securities and Exchange Commission has alleged.